Skip to content

Clinical trials

Phase 3 Myeloproliferative Disorders trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Phase: Phase 3 Country / region: Germany Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20101
20111
20121
20131
20144
20192
20201
20215
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Active, not recruiting4
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene3
Novartis Pharmaceuticals3
CTI BioPharma2
Fred Hutchinson Cancer Center2
Incyte Corporation2
AOP Orphan Pharmaceuticals AG1
Ariad Pharmaceuticals1
European Organisation for Research and Treatment of Cancer - EORTC1
European Working Group of MDS in Childhood1
Geron Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders20
Primary Myelofibrosis9
Bone Marrow Diseases7
Hematologic Diseases7
Anemia5
Polycythemia Vera5
Leukemia4
Myelodysplastic Syndromes4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Leukemia, Myeloid, Acute2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.